Altre lingue Heart Test Laboratories, Inc.

Azioni

HSCS

US42254E3027

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 10/07/2024			Variaz. 5gg	Var. 1 gen.
4,42 ^USD	-5,35%		-6,95%	-74,15%

24/04	HeartSciences annuncia la concessione di un brevetto fondamentale da parte dell'Ufficio Brevetti Europeo, riguardante la valutazione della funzione diastolica del cuore mediante AI-ECG.	CI
26/03	HeartSciences annuncia la presentazione sul podio al Congresso Mondiale degli Anestesisti dell'utilità dell'ECG wavelet MyoVista® per il rilevamento della disfunzione diastolica ventricolare sinistra nei pazienti preoperatori.	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

HeartSciences Regains Compliance with Nasdaq Listing Requirements	04/06
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio	20/05
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	24/04
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	24/04
HeartSciences to Present at the LD Micro Invitational XIV Conference	02/04
HeartSciences to Present at the LD Micro Invitational XIV Conference	02/04
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	26/03
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	26/03
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results	14/03
Heart Test Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	14/03
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes	12/03
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology	06/03
HeartSciences Adds Key Advisor to its Scientific Advisory Board	26/02
HeartSciences Adds Key Advisor to its Scientific Advisory Board	26/02
Heart Test Laboratories, Inc. Appoints Partho P. Sengupta to Its Scientific Advisory Board	26/02
HeartSciences Expands its Scientific Advisory Board	12/02
Heart Test Laboratories, Inc. Appoints Jordan B. Strom to Its Scientific Advisory Board	12/02
HeartSciences Appoints New Scientific Advisory Board Member	01/02
HeartSciences Appoints New Scientific Advisory Board Member	01/02
HeartSciences Appoints Benjamin Glicksberg to its Scientific Advisory Board	01/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Heart Test Laboratories, Inc.

Azioni

HSCS

US42254E3027

Altre lingue

Filtri